Reaction
Adenoviral Haemorrhagic Cystitis reporting signals
As of the last recalculation, Adenoviral Haemorrhagic Cystitis appears in 208 FAERS reports alongside 10 co-occurring drug terms. The strongest observed disproportionality signal is FLUDARABINE PHOSPHATE (PRR 176.1).
Important: FAERS is a spontaneous, voluntary, unverified reporting system. PRR and ROR identify reporting patterns for investigation; they are not incidence rates and do not establish causation.
| Drug | Co-reports | PRR | ROR |
|---|---|---|---|
| Fludarabine Phosphate | 52 | 176.1 | 176.3 |
| Basiliximab | 13 | 117.9 | 118.1 |
| Melphalan | 22 | 108.1 | 108.2 |
| Melphalan Hydrochloride | 23 | 103.1 | 103.2 |
| Micafungin Sodium | 8 | 98.2 | 98.2 |
| Axicabtagene Ciloleucel | 9 | 95.3 | 95.4 |
| Ganciclovir | 9 | 91.9 | 92.0 |
| Ganciclovir Sodium | 9 | 88.9 | 89.0 |
| Busulfan | 13 | 88.1 | 88.2 |
| Blinatumomab | 7 | 69.4 | 69.5 |